Drug Type T-lymphocyte cell therapy |
Synonyms- |
Target- |
Mechanism T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Stomach Cancer | Phase 1 | - | 01 Aug 2022 | |
Stomach Cancer | Phase 1 | - | 01 Aug 2022 |